Causes for hilar calcified lymph nodes
causes hilar calcified lymph nodes radiology differential diagnosis
| Cause | Pattern of Calcification | Laterality | Key Clue |
|---|---|---|---|
| Tuberculosis | Dense, homogeneous | Unilateral | Ghon complex; caseous necrosis |
| Histoplasmosis | Dense, diffuse | Unilateral or bilateral | Endemic area; fibrosing mediastinitis |
| Sarcoidosis | Stippled or eggshell | Bilateral, symmetric | BHL; systemic features |
| Silicosis | Eggshell (pathognomonic) | Bilateral | Occupational silica exposure |
| Treated lymphoma | Dense, irregular | Variable | Prior RT/chemo history |
| CWP | Variable | Bilateral | Coal/dust exposure |
| Fibrosing mediastinitis | Extensive, diffuse | Focal (right-sided) | SVC obstruction |
| Other fungi | Dense | Variable | Immunocompromise |
Bilateral fully calcified
bilateral fully calcified hilar lymph nodes differential diagnosis causes
| Feature | Sarcoidosis | Silicosis/CWP | Histoplasmosis | TB |
|---|---|---|---|---|
| Laterality | Bilateral, symmetric | Bilateral | Often R-sided/focal | Usually unilateral |
| Calcification type | Stippled → dense | Eggshell → dense | Dense/homogeneous | Dense |
| Parenchymal findings | Upper/mid-zone nodules, fibrosis | Upper-zone nodules, PMF | "Buckshot" calcifications | Apical fibro-cavitary disease |
| Key clue | Hypercalcaemia, ACE↑, systemic features | Occupational silica exposure | Endemic area exposure | TB contact, PPD/IGRA |
| Node symmetry | Symmetric | Symmetric | Asymmetric | Asymmetric |
What additional lab/imaging tests confirm each diagnosis
| Test | Finding | Notes |
|---|---|---|
| Serum ACE | Elevated (↑) in ~60–75% | Not specific; also raised in TB, histoplasmosis, berylliosis — use for monitoring, not diagnosis alone |
| Serum calcium | Hypercalcaemia in ~10–20% | Due to 1α-hydroxylase in granulomas converting 25-OH vit D → 1,25-(OH)₂ vit D |
| 24-hr urine calcium | Hypercalciuria (~40%) | More sensitive than serum calcium |
| FBC/ESR | Lymphopenia, elevated ESR | Non-specific |
| LFTs | Elevated ALP/GGT if hepatic involvement | |
| Serum LDH, IL-2R | Elevated | Markers of granuloma burden |
| Test | Finding |
|---|---|
| HRCT chest | Bilateral symmetric hilar + mediastinal adenopathy; perilymphatic micronodules (upper/mid zones); beading along bronchovascular bundles; "galaxy sign" |
| PET-CT | FDG-avid hilar/mediastinal nodes; useful to identify best biopsy site |
| Gallium-67 scan | "Panda sign" (parotid + lacrimal uptake) + "lambda sign" (hilar + right paratracheal uptake) — now largely replaced by PET |
| Test | Finding |
|---|---|
| CXR (ILO classification) | Small rounded opacities (p/q/r), upper-zone predominant; bilateral hilar enlargement ± eggshell calcification |
| HRCT chest | Bilateral upper-lobe centrilobular and subpleural nodules; eggshell or dense hilar node calcification; progressive massive fibrosis (PMF) as large upper-zone opacities |
| Test | Purpose |
|---|---|
| PFTs (spirometry + DLCO) | Restrictive or mixed pattern; reduced DLCO in advanced disease |
| IGRA / Tuberculin test (TST) | Screen for concomitant TB (silicosis ↑ TB risk significantly) |
| Sputum AFB smear + culture | Rule out active TB |
| ANA, RF | Silicosis is associated with scleroderma and RA (Caplan syndrome) |
| Test | Finding | Notes |
|---|---|---|
| Histoplasma urine antigen (EIA) | Positive | Most sensitive for acute disseminated or severe pulmonary disease; may be negative in chronic/healed disease |
| Serum Histoplasma antigen | Positive | Less sensitive than urine |
| Complement fixation (CF) IgG/IgM | Titre ≥1:32 or 4× rise | Supports active/recent infection; cross-reacts with Blastomyces, Coccidioides |
| Immunodiffusion (ID) bands | H and M precipitin bands | M band = active or recent; H band = active disease |
| BAL fluid antigen + cytology | Positive/yeast forms seen | For acute pulmonary form |
| Test | Finding |
|---|---|
| HRCT chest | Mediastinal/hilar calcified mass; "buckshot" parenchymal calcifications; may show fibrosing mediastinitis with vascular encasement |
| Test | Finding |
|---|---|
| IGRA (QuantiFERON-TB Gold / T-SPOT) | Positive = evidence of TB infection (past or latent); cannot distinguish active from latent |
| TST (Mantoux) | ≥10 mm induration (≥5 mm if immunocompromised) |
| Sputum AFB smear × 3 | Positive = active TB (fast); negative does not exclude |
| Sputum mycobacterial culture (LJ/MGIT) | Gold standard for active TB; 2–6 weeks |
| Sputum GeneXpert MTB/RIF (NAAT) | Rapid (2 hrs); detects MTB + rifampicin resistance; very high sensitivity |
| Test | Finding |
|---|---|
| HRCT chest | Old TB: calcified nodes, apical fibro-nodular scarring, calcified granulomas; active TB: tree-in-bud pattern, cavitation, consolidation |
| CT abdomen/pelvis | If extrapulmonary TB suspected |
| Diagnosis | First-line Tests |
|---|---|
| Sarcoidosis | Serum ACE + calcium; HRCT; EBUS-TBNA (non-caseating granuloma) |
| Silicosis | Occupational history; HRCT; PFTs; IGRA (rule out TB) |
| Histoplasmosis | Urine + serum Histoplasma antigen; CF/ID serology; BAL culture |
| Tuberculosis | GeneXpert / sputum AFB × 3; IGRA; HRCT |
| CWP | Occupational history; HRCT; ILO CXR classification |
| Treated lymphoma | Clinical history; PET-CT for relapse |
No occupational exposure, no history of PTB, no history of treated lymphoma, CT Chest- bilateral lower lobe atelectasis, calcified nodes in hilar, prevascular, subcarinal